Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Profile of Gut Microbiota of Adults with Diabetes Mellitus Type 1: A Systematic Review

Author(s): Larissa Almenara Abreu Moreira*, Larissa da Paz Lima, Maíra Aparecida de Oliveira Falcão and Eliane Lopes Rosado

Volume 19, Issue 4, 2023

Published on: 28 June, 2022

Article ID: e280322202706 Pages: 9

DOI: 10.2174/1573399818666220328150044

Price: $65

Abstract

Background: Type 1 diabetes mellitus (T1DM) is a chronic disease of clinical importance, whose prevalence has increased in Brazil and worldwide. Among the possible factors involved in the genesis and control of the disease, the intestinal microbiota (IM) deserves to be highlighted, but studies that report differences between the IM of patients with T1DM and those who are healthy are still contradictory and scarce.

Objective: The objective of this paper was to evaluate the IM profile of T1DM and healthy patients, in order to verify possible differences and to evaluate the possibility of the influence of IM on glycemic control in T1DM.

Methods: Of the 2716 articles found, nine were included in this review, and all of which were randomized, observational, cross-sectional, cohort and case-control studies that characterized the composition of IM in adults with T1DM and healthy adults.

Results: Studies are very diverse, which makes it difficult to associate the IM profile with T1DM etiology and control, however it was found that there was a prevalence of the phylum Firmicutes in the IM of individuals with T1DM and that there was no significant difference in the relative abundance of Bacteroidetes in both populations.

Conclusion: It was also possible to identify an inverse relationship of the genus Bifidobacterium and a positive relationship of the genera Bacteroidetes and Prevotella with the concentration ofglycated hemoglobin. More studies are needed to contemplate the characterization of IM in healthy and T1DM individuals.

Keywords: Intestinal microbiota, microbiome, type 1 diabetes mellitus, microbiota, diabetes mellitus, intestinal microbiome.

[1]
SBD. Sociedade brasileira de diabetes. Diretrizes Sociedade Brasileira de Diabetes 2019-2020. Available from: http://www.diabetes.org.br (Accessed: February 13, 2020).
[2]
IDF. International diabetes federation. IDF Diabetes Atlas. (7th ed..), Brussels, Belgium: International Diabetes Federation 2020. Available from: http://www.idf.org Accessed: February 13, 2020.
[3]
ADA. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2020; 43(1): 1-212.
[4]
Salamon D, Sroka-Oleksiak A, Kapusta P, et al. Characteristics of gut microbiota in adult patients with type 1 and type 2 diabetes based on next generation sequencing of the 16S rRNA gene fragment. Poli Archi Intern Medic 2018; 128(6): 336-43.
[http://dx.doi.org/10.20452/pamw.4246] [PMID: 29657308]
[5]
Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489(7415): 220-30.
[http://dx.doi.org/10.1038/nature11550] [PMID: 22972295]
[6]
Hugon P, Dufour JC, Colson P, Fournier PE, Sallah K, Raoult D. A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect Dis 2015; 15(10): 1211-9.
[http://dx.doi.org/10.1016/S1473-3099(15)00293-5] [PMID: 26311042]
[7]
Moraes AC, Silva IT, Almeida-Pititto B, Ferreira SR. Intestinal microbiota and cardiometabolic risk: Mechanisms and diet modulation. Arq Bras Endocrinol Metabol 2014; 58(4): 317-27.
[http://dx.doi.org/10.1590/0004-2730000002940] [PMID: 24936725]
[8]
Murri M, Leiva I, Gomez-Zumaquero JM, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study. BMC Med 2013; 11(1): 46.
[http://dx.doi.org/10.1186/1741-7015-11-46] [PMID: 23433344]
[9]
Gülden E, Wong FS, Wen L. The gut microbiota and type 1 diabetes. Clin Immunol 2015; 159(2): 143-53.
[10]
Moher D, Altman DG, Liberati A, Tetzlaff J. PRISMA statement. Epidemiology 2011; 22(1): 128.
[http://dx.doi.org/10.1097/EDE.0b013e3181fe7825] [PMID: 21150360]
[11]
Wells GA, Shea B, O'Connell D, et al. The 303 newcastle-ottawa scale (NOS) for assessing the quailty of nonrandomised studies 304 in meta-analysis. 2020. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Acessed: February 13, 2020).
[http://dx.doi.org/10.1016/j.clim.2015.05.013] [PMID: 26051037]
[12]
Higuchi BS, Rodrigues N, Gonzaga MI, et al. Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study. Front Immunol 2018; 9: 1689.
[http://dx.doi.org/10.3389/fimmu.2018.01689] [PMID: 30090100]
[13]
Alkanani AK, Hara N, Gottlieb PA, et al. Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes 2015; 64(10): 3510-20.
[http://dx.doi.org/10.2337/db14-1847] [PMID: 26068542]
[14]
Huang Y, Li SC, Hu J, et al. Gut microbiota profiling in Han Chinese with type 1 diabetes. Diabetes Res Clin Pract 2018; 141: 256-63.
[http://dx.doi.org/10.1016/j.diabres.2018.04.032] [PMID: 29733871]
[15]
Demirci M, Bahar Tokman H, Taner Z, et al. Bacteroidetes and Firmicutes levels in gut microbiota and effects of hosts TLR2/TLR4 gene expression levels in adult type 1 diabetes patients in Istanbul, Turkey. J Diabetes Complications 2020; 34(2): 107449.
[http://dx.doi.org/10.1016/j.jdiacomp.2019.107449] [PMID: 31677982]
[16]
Stewart CJ, Nelson A, Campbell MD, et al. Gut microbiota of Type 1 diabetes patients with good glycaemic control and high physical fitness is similar to people without diabetes: An observational study. Diabet Med 2017; 34(1): 127-34.
[http://dx.doi.org/10.1111/dme.13140] [PMID: 27100052]
[17]
Fassatoui M, Lopez-Siles M, Díaz-Rizzolo DA, et al. Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus. Biosci Rep 2019; 39(6): BSR20182348.
[http://dx.doi.org/10.1042/BSR20182348] [PMID: 31147456]
[18]
de Groot PF, Belzer C, Aydin Ö, et al. Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study. PLoS One 2017; 12(12): e0188475.
[http://dx.doi.org/10.1371/journal.pone.0188475] [PMID: 29211757]
[19]
Pellegrini S, Sordi V, Bolla AM, et al. Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota. J Clin Endocrinol Metab 2017; 102(5): 1468-77.
[http://dx.doi.org/10.1210/jc.2016-3222] [PMID: 28324102]
[20]
Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011; 5(1): 82-91.
[http://dx.doi.org/10.1038/ismej.2010.92] [PMID: 20613793]
[21]
de Goffau MC, Luopajärvi K, Knip M, et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013; 62(4): 1238-44.
[http://dx.doi.org/10.2337/db12-0526] [PMID: 23274889]
[22]
de Goffau MC, Fuentes S, van den Bogert B, et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 2014; 57(8): 1569-77.
[http://dx.doi.org/10.1007/s00125-014-3274-0] [PMID: 24930037]
[23]
Mejía-León ME, Barca AM. Diet, microbiota and immune system in type 1 diabetes development and evolution. Nutrients 2015; 7(11): 9171-84.
[http://dx.doi.org/10.3390/nu7115461] [PMID: 26561831]
[24]
Hornef MW, Pabst O. Real friends: Faecalibacterium prausnitzii supports mucosal immune homeostasis. Gut 2016; 65(3): 365-7.
[http://dx.doi.org/10.1136/gutjnl-2015-310027] [PMID: 26531718]
[25]
Jafarnejad S, Saremi S, Jafarnejad F, Arab A. Effects of a multispecies probiotic mixture on glycemic control and inflammatory status in women with gestational diabetes: A randomized controlled clinical trial. J Nutr Metab 2016; 2016: 5190846.
[http://dx.doi.org/10.1155/2016/5190846]
[26]
Endesfelder D, zu Castell W, Ardissone A, et al. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 2014; 63(6): 2006-14.
[http://dx.doi.org/10.2337/db13-1676] [PMID: 24608442]
[27]
Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology 2017; 151(4): 363-74.
[http://dx.doi.org/10.1111/imm.12760] [PMID: 28542929]
[28]
Shin NR, Lee JC, Lee HY, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose home-ostasis in diet-induced obese mice. Gut 2014; 63(5): 727-35.
[http://dx.doi.org/10.1136/gutjnl-2012-303839] [PMID: 23804561]

Rights & Permissions Print Cite
Article Metrics
30
2
© 2024 Bentham Science Publishers | Privacy Policy